The next-generation BeneHeart series defibrillators are designed to provide superior reliability, comprehensive diagnosis, and monitoring tools for both in-hospital and pre-hospital rescue, along with several upgraded features
The new BeneHeart D60 and D30 defibrillators. (Credit: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.)
Chinese medical device company Mindray has rolled out its next-generation BeneHeart series defibrillators, BeneHeart D60 and D30, to raise the standards for resuscitation.
The next-generation BeneHeart series defibrillators are designed to offer superior reliability, comprehensive diagnosis, and monitoring tools for both in-hospital and pre-hospital rescue.
They feature several upgrades, including a high-definition large screen that supports gesture controls, while physical knobs and buttons are still available.
Mindray said that the new defibrillators weigh only 4.2kg with the battery, come with water and dust-proof, drop-protection, and can operate in extreme temperatures (-20°C to 55°C).
Also, they are equipped with the patented QShock and filtered ECG analysis technologies that reduce the charging and interruption time for faster defibrillation, said the company.
Mindray International PMLS sales and marketing general manager Mark Sun said: “Defibrillators play a critical role in reducing all-cause mortality and emergencies. Emergency care demands no less than the highest requirement of efficiency and effectiveness to save a patient’s life.
“With the new BeneHeart defibrillation solution, a combination of diagnosis, monitoring, and treatment solutions for emergencies, we aim to unlock the full potential to help clinicians quickly and confidently navigate the difficult situations they encounter.”
According to Mindray, the new BeneHeart D60 and D30 defibrillators provide a comprehensive CPR evaluation system to monitor real-time CPR performance.
They are also embedded with structured debriefing protocols to support automatic rescue data recording and uploading to improve performance, and support training modes.
The company said that BeneHeart D60 features multiple diagnosis and analysis functions for complex pre-hospital environments.
The defibrillator offers professional 12-lead ECG analysis functions with intelligent assistance along with a six-channel recorder that generates real-time ECG reports.
Its point-of-care ultrasound function enables accurate decision-making, using trauma identification tools, operation guides, and reference images.
Furthermore, the device can remotely send the diagnosis reports to the target hospital, enabling advanced treatment planning, said the medical device maker.